Synthesis and Characterization of Memantine-Loaded Niosomes for Enhanced Alzheimer’s Disease Targeting
<b>Background/Objectives:</b> Over the past 25 years, numerous biological molecules, like recombinant lysosomal enzymes, neurotrophins, receptors, and therapeutic antibodies, have been tested in clinical trials for neurological diseases. However, achieving significant success in clinical...
Saved in:
| Main Authors: | Hasan Turkez, Sena Oner, Ozge Caglar Yıldırım, Mehmet Enes Arslan, Marilisa Pia Dimmito, Çigdem Yuce Kahraman, Lisa Marinelli, Erdal Sonmez, Özlem Kiki, Abdulgani Tatar, Ivana Cacciatore, Antonio Di Stefano, Adil Mardinoglu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/2/267 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Evaluation of Memantine Effect on Tinnitus Severity
by: Babak Pourayyoubi, et al.
Published: (2025-07-01) -
Effects of CAPAH, memantine, and rivastigmine on behavioral and cognitive functions of rats
by: D. O. Nikitin, et al.
Published: (2024-11-01) -
Memantine-induced delayed sleep phase in Huntington’s disease: A case report
by: Youshi Fujita, et al.
Published: (2025-01-01) -
EXPERIENCE WITH THE DRUG MEMANTINE IN PATIENTS WITH FOCAL EPILEPSY AND COGNITIVE IMPAIRMENT
by: Yu. V. Solomatin, et al.
Published: (2016-05-01) -
Niosome Preparation Techniques and Structure—An Illustrated Review
by: Saeid Mezail Mawazi, et al.
Published: (2025-01-01)